Clients bring us projects of all types and sizes because we consistently work with them to achieve their research goals and enable them to focus on their part of the research process.
INTERNATIONAL POINT OF CARE INC.Located in Toronto, Canada, International Point of Care Incorporated, develops, manufactures and supplies unique biological reagents, raw materials, and lateral flow components for the in-vitro diagnostic industry and the research and development community. IPOC's specialty has been in the areas of rapid point-of care-testing and our customers represent a strong mix of established global biotech companies and small dedicated research labs and institutes around the world.
Concept2Clinic Incorporated is an executive R&D management company built on the 'united we stand, divided we fail' concept. In today's economy and with the complexity of drug development and global regulatory requirements, it is impossible for any one entity to do it all themselves. At C2C we realize and embrace this and consequently work with our clients, the regulators, and network of consultants and preferred service providers to make clinical investigation of your intellectual property a reality. What we bring to the table is a fully integrated drug development team with an aggregate 198 years of pharmaceutical development experience. When C2C signs a contract, we take full accountability for your drug development program and will act as your entire R&D division, removing the need for you to develop this infrastructure on a full time basis. C2C will provide your company with a 'part-time' R&D Executive who will be an integral part of your management team to help define your development strategy, ensure compliance with global regulatory requirements and make certain the development is technically sound with execution on time and on budget.
Concept2Clinic Incorporated is an executive R&D management company built on the 'united we stand, divided we fail' concept. In today's economy and with the complexity of drug development and global regulatory requirements, it is impossible for any one entity to do it all themselves. At C2C we realize and embrace this and consequently work with our clients, the regulators, and network of consultants and preferred service providers to make clinical investigation of your intellectual property a reality. What we bring to the table is a fully integrated drug development team with an aggregate 198 years of pharmaceutical development experience.